Pharmacological and Environmental Determinants of Relapse to Cocaine-Seeking Behavior

Animal models have been developed that simulate relevant features of relapse to cocaine-seeking behavior in humans. These models have provided valuable information about pharmacological and environmental factors that precipitate reinstatement of extinguished cocaine-seeking in rats and monkeys, as well as new insights about potential pharmacotherapies for relapse prevention. Reinstatement of cocaine-seeking behavior in animals can be induced by cocaine priming or by cocaine-paired environmental stimuli: however, maximum reinstatement of drug-seeking appears to be induced when cocaine priming and cocaine-paired stimuli are combined. Drugs that share cocaine's indirect dopamine agonist properties or that act as direct agonists at D2-like dopamine receptors also induce reinstatement of cocaine-seeking behavior, whereas with some exceptions (e.g., caffeine, morphine) drugs from other pharmacological classes do not. D1-like receptor agonists block rather than mimic the priming effects of cocaine, suggesting different roles for D1- and D2-like receptor mechanisms in cocaine relapse. Although considerable overlap exists, drugs that exhibit cocaine-like discriminative stimulus and/ or reinforcing effects in other situations do not invariably induce cocaine-like reinstatement of drug-seeking and vice versa, implying that these effects are not simply different behavioral expressions of a unitary neurobiological process. Finally, recent findings with D1-like receptor agonists, partial agonists, and antagonists suggest that some of these drugs may be viable candidates for development as antirelapse pharmacotherapies.

[1]  D J Rohsenow,et al.  Cue reactivity in addictive behaviors: theoretical and treatment implications. , 1990, The International journal of the addictions.

[2]  R. Ehrman,et al.  Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. , 1990, Addictive behaviors.

[3]  A. Alterman,et al.  How effective is substance abuse treatment--compared to what? , 1992, Research publications - Association for Research in Nervous and Mental Disease.

[4]  R. A. Fuchs,et al.  Predictive validity of the extinction/reinstatement model of drug craving , 1998, Psychopharmacology.

[5]  I. Creese,et al.  The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat , 1987, Neuroscience Letters.

[6]  K. Rice,et al.  Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. , 1995 .

[7]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[8]  S. B. Caine,et al.  Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. , 1993, Science.

[9]  K. Johnson,et al.  Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.

[10]  Jane Stewart,et al.  Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area , 1984, Pharmacology Biochemistry and Behavior.

[11]  F. Gawin.  Cocaine addiction: psychology and neurophysiology. , 1991, Science.

[12]  Animal models of relapse , 1996 .

[13]  A. Wikler.  Some implications of conditioning theory for problems of drug abuse. , 1971, Behavioral science.

[14]  M. Brocco,et al.  Reinstatement of responding maintained by cocaine or thiamylal. , 1984, The Journal of pharmacology and experimental therapeutics.

[15]  J. Witkin,et al.  Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. , 1991, The Journal of pharmacology and experimental therapeutics.

[16]  K. Rice,et al.  Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations. , 1995 .

[17]  H. Kleber.  Pharmacotherapy, current and potential, for the treatment of cocaine dependence , 1995 .

[18]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[19]  E. Nestler,et al.  Relapse to drug-seeking: neural and molecular mechanisms. , 1998, Drug and alcohol dependence.

[20]  R. Spealman,et al.  Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.

[21]  R. Spealman,et al.  Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. , 1996, The Journal of pharmacology and experimental therapeutics.

[22]  O. Civelli,et al.  Dopamine receptor diversity: molecular and pharmacological perspectives. , 1997, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[23]  L. Dwoskin,et al.  The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  M. Martres,et al.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.

[25]  J. Ginos,et al.  Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. , 1984, The Journal of pharmacology and experimental therapeutics.

[26]  G. Vaillant.  Is there a natural history of addiction? , 1992, Research publications - Association for Research in Nervous and Mental Disease.

[27]  E. Nestler,et al.  Opposite Modulation of Cocaine-Seeking Behavior by D1- and D2-Like Dopamine Receptor Agonists , 1996, Science.

[28]  S. Ögren,et al.  Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. , 1993, Pharmacology & toxicology.

[29]  M. Weed,et al.  The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.

[30]  R. Wise,et al.  Brain dopamine and reward. , 1989, Annual review of psychology.

[31]  L. Stein,et al.  The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats , 1992, Brain Research.

[32]  R. Spealman,et al.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[33]  J. Stewart,et al.  Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period , 1996, Psychopharmacology.

[34]  D. Hommer,et al.  Preferential effects of caffeine on limbic and cortical dopamine systems , 1988, Biological Psychiatry.

[35]  Davis Wm,et al.  Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. , 1976 .

[36]  M. Le Moal,et al.  Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Preston,et al.  Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. , 1992, NIDA research monograph.

[38]  S. Schenk,et al.  Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine , 1994, Pharmacology Biochemistry and Behavior.

[39]  Y. Shaham,et al.  Corticotropin-Releasing Factor, But Not Corticosterone, Is Involved in Stress-Induced Relapse to Heroin-Seeking in Rats , 1997, The Journal of Neuroscience.

[40]  H. Wikström,et al.  Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. , 1995, European journal of pharmacology.

[41]  P. Sokoloff,et al.  Novel dopamine receptors half a decade later. , 1995, Trends in pharmacological sciences.

[42]  J. Jaffe,et al.  HALOPERIDOL-INDUCED DYSTONIA IN COCAINE ADDICTS , 1986, The Lancet.

[43]  M. Marinelli,et al.  Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. , 1997, The Journal of pharmacology and experimental therapeutics.

[44]  C. Niemegeers,et al.  Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments , 1979, Pharmacology Biochemistry and Behavior.

[45]  R. Ehrman,et al.  Classically conditioned responses in opioid and cocaine dependence: a role in relapse? , 1988, NIDA research monograph.

[46]  M. Starr,et al.  The role of dopamine in epilepsy , 1996, Synapse.

[47]  R. A. Fuchs,et al.  Effects of D3‐preferring agonists 7‐OH-PIPAT and PD‐128,907 on motor behaviors and place conditioning , 1997, Behavioural pharmacology.

[48]  B. Rounsaville,et al.  One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. , 1994, Archives of general psychiatry.

[49]  R. Ehrman,et al.  Cue reactivity and cue reactivity interventions in drug dependence. , 1993, NIDA research monograph.

[50]  F. O’Doherty.  Is drug use a response to stress? , 1991, Drug and alcohol dependence.

[51]  M. Haney,et al.  Effects of pergolide on intravenous cocaine self-administration in men and women , 1998, Psychopharmacology.

[52]  R. T. Kelleher,et al.  Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections , 1979, Neuropharmacology.

[53]  P. Bridge,et al.  Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials : (NIDA Research Monograph ; 175) , 1997 .

[54]  F. Tennant,et al.  Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. , 1987, Archives of internal medicine.

[55]  D. Gauvin,et al.  Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats , 1989, Pharmacology Biochemistry and Behavior.

[56]  S. Goldberg.  Stimuli associated with drug injections as events that control behavior. , 1975, Pharmacological reviews.

[57]  L. Bednarz,et al.  Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431. , 1996, European journal of pharmacology.

[58]  S. H. Ahmed,et al.  Cocaine-but not food-seeking behavior is reinstated by stress after extinction , 1997, Psychopharmacology.

[59]  E. Nestler,et al.  Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Self-Administration and Relapse of Cocaine-Seeking Behavior , 1998, The Journal of Neuroscience.

[60]  R. Ranaldi,et al.  Initiation, maintenance and extinction of cocaine self-administration with and without conditioned reward , 1996, Psychopharmacology.

[61]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  N. Mello,et al.  Preclinical Evaluation of Pharmacotherapies for Treatment of Cocaine and Opioid Abuse Using Drug Self-Administration Procedures , 1996, Neuropsychopharmacology.

[63]  C. Haertzen,et al.  Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. , 1991, NIDA research monograph.

[64]  R. Spealman,et al.  Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. , 1992, The Journal of pharmacology and experimental therapeutics.

[65]  J. Woods,et al.  The Conditioned Reinforcing Effects of Stimuli Associated with Morphine Reinforcement , 1968 .

[66]  M. Kreek.  Rationale for maintenance pharmacotherapy of opiate dependence. , 1992, Research publications - Association for Research in Nervous and Mental Disease.

[67]  R. Ehrman,et al.  Relationships among physiological and self-report responses produced by cocaine-related cues. , 1997, Addictive behaviors.

[68]  McCance Ef.  Overview of potential treatment medications for cocaine dependence. , 1997 .

[69]  W. H. Morse,et al.  Second-Order Schedules of Drug Injection , 1975 .

[70]  R. Spealman,et al.  Antagonism of cocaine self‐administration by selective dopamine D1 and D2 antagonists , 1990, Behavioural pharmacology.

[71]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[72]  T. Järbe,et al.  Discriminative stimulus properties of cocaine Effects of apomorphine, haloperidol, procaine and other drugs , 1984, Neuropharmacology.

[73]  N K Mello,et al.  Management of cocaine abuse and dependence. , 1996, The New England journal of medicine.

[74]  M. Millan,et al.  A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. , 1998, The Journal of pharmacology and experimental therapeutics.

[75]  R. Spealman,et al.  Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[76]  R. Stretch,et al.  Drug-induced reinstatement of extinguished self-administration behavior in monkeys , 1975, Pharmacology Biochemistry and Behavior.

[77]  S. B. Caine,et al.  Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[78]  R. See,et al.  Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. , 1996, Behavioural pharmacology.

[79]  R. Spealman,et al.  Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists , 1997, Psychopharmacology.

[80]  R. Spealman.  Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. , 1996, The Journal of pharmacology and experimental therapeutics.

[81]  S. Comer,et al.  Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. , 1993, The Journal of pharmacology and experimental therapeutics.